Winning Health Technology Group Co., Ltd. (SHE:300253)
6.98
+0.02 (0.29%)
Sep 30, 2026, 3:04 PM CST
SHE:300253 Market Cap
SHE:300253 has a market cap or net worth of 15.36 billion as of October 6, 2026. Its market cap has decreased by -22.64% in one year.
Market Cap
15.36B
Enterprise Value
14.92B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.98
ChartMarket Cap Chart
Since August 18, 2011, SHE:300253's market cap has increased from 2.30B to 15.36B, an increase of 568.36%. That is a compound annual growth rate of 13.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 15.36B | -20.83% |
| Dec 31, 2025 | 19.41B | 24.79% |
| Dec 31, 2024 | 15.55B | 1.39% |
| Dec 29, 2023 | 15.34B | -30.06% |
| Dec 30, 2022 | 21.93B | -39.02% |
| Dec 31, 2021 | 35.97B | -3.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi AppTec | 499.43B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 311.34B |
| Shenzhen Mindray Bio-Medical Electronics | 195.10B |
| Sichuan Biokin Pharmaceutical | 99.92B |
| BrightGene Bio-Medical Technology | 15.59B |
| Liaoning Cheng Da | 15.54B |
| GemPharmatech | 15.52B |
| Tonghua Dongbao Pharmaceutical | 15.38B |